Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 324

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 324
---
 as well as the named inventor
of a number of pharmaceutical patents. Dr. Angel received his B.S. and M.Sc. in Biology from Tel-Aviv University, Israel, cum laude in
1979, and received Ph.D. cum laude from the Hamburg University, Germany in 1982.

As
part of his consulting services, Dr. Angel shall assist our company with (i) pharmaceutical regulatory affairs, toxicology, drug research
and pre-clinical and clinical testing, (ii) outsourcing and helping our company in managing third party vendors and (iii) working with
our company in our interactions with regulatory bodies.

Board
Composition

Our
business and affairs are managed under the direction of our board of directors, which currently consists of five members. The number
of directors is determined by our board of directors, subject to the terms of our amended and restated articles of incorporation and
bylaws that. Our directors are elected for one-year terms.

Family
Relationships

There
are no family relationships among any of our directors and executive officers.

Director
Independence

Our
board of directors has undertaken a review of the independence of each director. Based on information provided by each director concerning
his or her background, employment, and affiliations, our board of directors has determined that Matthew Whalen, Dr. Matthew Del Giudice,
Dr. Denil Shekhat and Edward MacPherson do not have any relationship that would interfere with the exercise of independent judgment in
carrying out the responsibilities of a director and are independent directors under the Nasdaq Listing Rules.

In
making these determinations, our board of directors considered the current and prior relationships that each non-employee director has
with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including
the transactions described in the section of this Report titled “Item 13. Certain Relationships and Related Party Transactions.”

Committees
of the Board of Directors

Our
board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee.
The functions of these committees are described below. Members will serve on these committees until their resignation or until otherwise
determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from
time to time.

68

Audit
Committee

Our
audit committee consists of Matthew Whalen, Dr. Denil Shekhat and Edward MacPherson, with Matthew Wh